| Product Name | (R)-(+)-Tolvaptan |
| Product Code | DA-T117-m |
| Chemical name | (R)-(+)-Tolvaptan |
| Synonyms | (R)-N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; N-[4-[[(5R)-7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl]carbonyl]-3-methylphenyl]-2-methylbenzamide; (R)-Tolvaptan; (R)-(+)-OPC 41061; |
| Impurity | NA |
| CAS Number | 331947-66-1 |
| Alternate CAS # | NA |
| Molecular form | C26H25ClN2O3 |
| Appearance | Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 448.95 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | An enantiomer of Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
